Page 3 - 2 Dg News Today

Updated: Developed with DRL, it reduces oxygen-dependence in patients Share Article AAA Defence Minister Rajnath Singh hands over the first batch of 2-DG anti Covid drug to the Union Health Minister Harsh Vardhan, in New Delhi on May 17, 2021. Photo: Twitter/@rajnathsingh   Developed with DRL, it reduces oxygen-dependence in patients The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along wit...

COVID-19: The 2-G drug had shown promising results in its phase 2 and phase 3 clinical trials. New Delhi: An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital. The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddys Laboratories. The ...

2-DG s therapeutic use for COVID-19 is set to begin in the coming week. However, there are several gaps in the information surrounding the drug trials and a lack of available data.

Pharma major Dr Reddy’s Laboratories Ltd net profit decreased 28 per cent at ₹554 crore in the fourth quarter ended March 31, 2021 as against ₹764 crore in the corresponding quarter of the previous

The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad. In his virtual address at the 25th meeting of the Group of Ministers, the Health Minister said, “180 districts have showed no fresh...